Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Towards solving the genetic diagnosis odyssey in Iranian patients with congenital anomalies

Abstract

Understanding the underlying causes of congenital anomalies (CAs) can be a complex diagnostic journey. We aimed to assess the efficiency of exome sequencing (ES) and chromosomal microarray analysis (CMA) in patients with CAs among a population with a high fraction of consanguineous marriage. Depending on the patient’s symptoms and family history, karyotype/Quantitative Fluorescence- Polymerase Chain Reaction (QF-PCR) (n = 84), CMA (n = 81), ES (n = 79) or combined CMA and ES (n = 24) were performed on 168 probands (66 prenatal and 102 postnatal) with CAs. Twelve (14.28%) probands were diagnosed by karyotype/QF-PCR and seven (8.64%) others were diagnosed by CMA. ES findings were conclusive in 39 (49.36%) families, and 61.90% of them were novel variants. Also, 64.28% of these variants were identified in genes that follow recessive inheritance in CAs. The diagnostic rate (DR) of ES was significantly higher than that of CMA in children from consanguineous families (P = 0·0001). The highest DR by CMA was obtained in the non-consanguineous postnatal subgroup and by ES in the consanguineous prenatal subgroup. In a population that is highly consanguineous, our results suggest that ES may have a higher diagnostic yield than CMA and should be considered as the first-tier test in the evaluation of patients with congenital anomalies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Study flowchart.
Fig. 2: Comparison of detection rate of ES and CMA in CA patients.
Fig. 3: Consanguinity and detection rate.
Fig. 4: Suggested genetic diagnostic algorithm for patients with CA.

Similar content being viewed by others

Data availability

The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.

References

  1. World Health Organization. Congenital anomalies. Fact sheet N 370. Available at who int/mediacentre/factsheet/fs370/en. 2015.

  2. Guide E. Instruction for the registration of congenital anomalies. Eurocat Cent Registry Dept Epidemiol, Cathol Univ Louvian, Bruss Pp. 1990;153:157.

    Google Scholar 

  3. Martínez‐Frías M, Bermejo E, Frias J. Pathogenetic classification of a series of 27,145 consecutive infants with congenital defects. Am J Med Genet. 2000;90:246–9.

    Article  PubMed  Google Scholar 

  4. Garne E, Dolk H, Loane M, Wellesley D, Barisic I, Calzolari E, et al. Paper 5: Surveillance of multiple congenital anomalies: implementation of a computer algorithm in European registers for classification of cases. Birth Defects Res Part A: Clin Mol Teratol. 2011;91:S44–50.

    Article  CAS  Google Scholar 

  5. Dobrescu MA, Burada F, Cucu MG, Riza AL, Chelu G, Plesea RM, et al. Prenatal genetic counseling in congenital anomalies. congenital anomalies-from the embryo to the neonate: IntechOpen. 2018.

  6. Zaidi S, Brueckner M. Genetics and genomics of congenital heart disease. Circulation Res. 2017;120:923–40.

    Article  CAS  PubMed  Google Scholar 

  7. Vivante A, Kohl S, Hwang D-Y, Dworschak GC, Hildebrandt F. Single-gene causes of congenital anomalies of the kidney and urinary tract (CAKUT) in humans. Pediatr Nephrol. 2014;29:695–704.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Leslie EJ, Marazita ML, editors. Genetics of cleft lip and cleft palate. American Journal of Medical Genetics Part C: Seminars in Medical Genetics; 2013: Wiley Online Library.

  9. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86:749–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Carss KJ, Hillman SC, Parthiban V, McMullan DJ, Maher ER, Kilby MD, et al. Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound. Hum Mol Genet. 2014;23:3269–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. He M, Du L, Xie H, Zhang L, Gu Y, Lei T, et al. The added value of whole-exome sequencing for anomalous fetuses with detailed prenatal ultrasound and postnatal phenotype. Front Genet. 2021;12:627204.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Vora NL, Powell B, Brandt A, Strande N, Hardisty E, Gilmore K, et al. Prenatal exome sequencing in anomalous fetuses: new opportunities and challenges. Genet Med. 2017;19:1207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hsu R-H, Lee C-H, Chien Y-H, Hwu P, Lee N-C. eP146: application of exome sequencing in patients of congenital anomalies with or without intellectual disability. Genet Med. 2022;24:S90.

    Article  Google Scholar 

  14. Weh E, Reis LM, Happ HC, Levin AV, Wheeler PG, David KL, et al. Whole exome sequence analysis of Peters anomaly. Hum Genet. 2014;133:1497–511.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Srivastava S, Love-Nichols JA, Dies KA, Ledbetter DH, Martin CL, Chung WK, et al. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders. Genet Med. 2019;21:2413–21.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23:2029–37.

    Article  PubMed  Google Scholar 

  17. Rashidi-Nezhad A, Fakhri L, Hantoush Zadeh S, Amini E, Sajjadian N, Hossein Zadeh P, et al. Evaluating the pre-, peri-and post-natal conditions of neonates affected by multiple congenital anomalies: a brief report. Tehran Univ Med J. 2013;70:659–64.

  18. Network NBDP. Appendix 3.1. Birth defects descriptions for NBDPN core, recommended, and extended conditions. Guidelines for conducting birth defects surveillance Atlanta, GA: National Birth Defects Prevention Network. 2015.

  19. Rashidi-Nezhad A, Parvaneh N, Farzanfar F, Azimi C, Harewood L, Akrami SM, et al. 2q34-qter duplication and 4q34. 2-qter deletion in a patient with developmental delay. Eur J Med Genet. 2012;55:203–10.

    Article  PubMed  Google Scholar 

  20. Badv RS, Mahdiannasser M, Rasoulinezhad M, Habibi L, Rashidi-Nezhad A. CEP104 gene may involve in the pathogenesis of a new developmental disorder other than joubert syndrome. Mol Biol Rep. 2022;49:7231–7.

    Article  CAS  PubMed  Google Scholar 

  21. Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Elsevier; 2020.

  22. McGowan-Jordan J, Hastings RJ, Moore S ISCN 2020: an international system for human cytogenomic nomenclature (2020). (No Title). 2020.

  23. Mahdiannasser M, Rashidi-Nezhad A, Badv RS, Akrami SM. Exploring the genetic etiology of drug-resistant epilepsy: incorporation of exome sequencing into practice. Acta Neurol Belgica. 2022;122:1457–68.

    Article  Google Scholar 

  24. Li H, Durbin R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics. 2009;25:1754–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–23.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Moorthie S, Blencowe H, Darlison MW, Lawn J, Morris JK, Modell B, et al. Estimating the birth prevalence and pregnancy outcomes of congenital malformations worldwide. J community Genet. 2018;9:387–96.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Ely DM, Driscoll AK Infant mortality in the United States, 2017: data from the period linked birth/infant death file. 2019.

  30. Staebler M, Donner C, Van Regemorter N, Duprez L, De Maertelaer V, Devreker F, et al. Should determination of the karyotype be systematic for all malformations detected by obstetrical ultrasound? Prenat Diagn. 2005;25:567–73.

    Article  CAS  PubMed  Google Scholar 

  31. Vand-Rajabpour F, Mousavi F, Kariminejad R, Bagherizadeh I, Bahadory K, Giti S, et al. Evaluation and Report of Array-CGH Utility in prenatal and postnatal diagnosis and abortion products referred to a Diagnostic Laboratory in Tehran. Sarem J Med Res. 2021;6:135–41.

    Article  Google Scholar 

  32. Evangelidou P, Sismani C, Ioannides M, Christodoulou C, Koumbaris G, Kallikas I, et al. Clinical application of whole-genome array CGH during prenatal diagnosis: Study of 25 selected pregnancies with abnormal ultrasound findings or apparently balanced structural aberrations. Mol Cytogenetics. 2010;3:1–10.

    Article  Google Scholar 

  33. Castells-Sarret N, Cueto-González AM, Borregan M, López-Grondona F, Miró R, Tizzano E, et al. Comparative genomic hybridisation as a first option in genetic diagnosis: 1000 cases and a cost–benefit analysis. An de Pediatría (Engl Ed). 2018;89:3–11.

    Google Scholar 

  34. Sagoo GS, Butterworth AS, Sanderson S, Shaw-Smith C, Higgins JP, Burton H. Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects. Genet Med. 2009;11:139–46.

    Article  CAS  PubMed  Google Scholar 

  35. Najafi K, Gholami S, Moshtagh A, Bazrgar M, Sadatian N, Abbasi G, et al. Chromosomal aberrations in pregnancy and fetal loss: Insight on the effect of consanguinity, review of 1625 cases. Mol Genet Genom Med. 2019;7:e820.

    Article  Google Scholar 

  36. Mohammadzadeh A, Akbaroghli S, Aghaei-Moghadam E, Mahdieh N, Badv RS, Jamali P, et al. Investigation of chromosomal abnormalities and microdeletion/microduplication (s) in fifty Iranian patients with multiple congenital anomalies. Cell J (Yakhteh). 2019;21:337.

    PubMed Central  Google Scholar 

  37. Drury S, Williams H, Trump N, Boustred C, GOSGene, Lench N, et al. Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities. Prenat Diagn. 2015;35:1010–7.

    Article  CAS  PubMed  Google Scholar 

  38. Ales M, Luca L, Marija V, Gorazd R, Karin W, Ana B, et al. Phenotype-driven gene target definition in clinical genome-wide sequencing data interpretation. Genet Med. 2016;18:1102.

    Article  CAS  Google Scholar 

  39. Retterer K, Juusola J, Cho MT, Vitazka P, Millan F, Gibellini F, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med. 2016;18:696–704.

    Article  CAS  PubMed  Google Scholar 

  40. Nambot S, Thevenon J, Kuentz P, Duffourd Y, Tisserant E, Bruel A-L, et al. Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis. Genet Med. 2018;20:645–54.

    Article  CAS  PubMed  Google Scholar 

  41. Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 2014;312:1870–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Najafi K, Mehrjoo Z, Ardalani F, Ghaderi-Sohi S, Kariminejad A, Kariminejad R, et al. Identifying the causes of recurrent pregnancy loss in consanguineous couples using whole exome sequencing on the products of miscarriage with no chromosomal abnormalities. Sci Rep. 2021;11:1–12.

    Article  Google Scholar 

  43. Stark Z, Schofield D, Alam K, Wilson W, Mupfeki N, Macciocca I, et al. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement. Genet Med. 2017;19:867–74.

    Article  PubMed  Google Scholar 

  44. Vissers LE, Van Nimwegen KJ, Schieving JH, Kamsteeg E-J, Kleefstra T, Yntema HG, et al. A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology. Genet Med. 2017;19:1055–63.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Jegathisawaran J, Tsiplova K, Ungar WJ A microcosting and cost-consequence analysis of genomic testing strategies (including trios) in autism spectrum disorder: an update. The Hospital for Sick Children: Technology Assessment at SickKids. 2019.

Download references

Acknowledgements

We are thankful to the all participants and their parents who have shown enthusiasm towards this project. We are grateful to the all nurses and other medical staffs who helped us in this project.

Funding

This study was supported by Tehran University of Medical Sciences through two grants to A.R.N. (grant no. 52367) and S.M.A. (grant no. 52355).

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: H.V., J.A.N., Y.C., S.M.A.; Supervision: S.M.A., A.R.N; Writing-original draft: H.V., S.M.A., A.R.N.; Data curation: H.V., L.H., Y.C., A.M., R.G., A.R.N.; Validation: H.V., N.F., R.R.N., T.S., M.M., M.M.D., R.K., A.R.N.; Software: A.A.; Resources: H.D., F.R.S., M.R.Z., V.G., P.S., A.N., T.E.S., Z.M., B.S., F.G., M.S., S.S., R.M., A.H., M.A.D.; Writing-review & editing: J.A.N., Y.C., R.G., A.H., S.M.A., A.R.N. All the authors approved the final draft.

Corresponding authors

Correspondence to Seyed Mohammad Akrami or Ali Rashidi-Nezhad.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

This study was performed in line with the principles of the Declaration of Helsinki. In particular, this research was conducted with the voluntary, informed consent of any research participants, free of coercion or coercive circumstances, and approval was granted by the research ethics committee of Tehran University of Medical Sciences (No. IR.TUMS.MEDICINE.REC.1399.1278).

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vaseghi, P., Habibi, L., Neidich, J.A. et al. Towards solving the genetic diagnosis odyssey in Iranian patients with congenital anomalies. Eur J Hum Genet (2024). https://doi.org/10.1038/s41431-024-01533-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41431-024-01533-x

This article is cited by

Search

Quick links